So Voronkova et al. demonstrated that SOX9 overexpression in NSCLC promotes drug resistance and Barbosa et al. showed in in vitro analyses that silencing of SOX2 enhances radioresistance while SOX9 silencing enhances radiosensitivity in HNSCC.10, 31. Here, SOX9 is linked to head and neck squamous cell carcinoma.